Correction: Value of combining biological age with assessment of individual frailty to optimize management of cancer treated with targeted therapies: model of chronic myeloid leukemia treated with tyrosine kinase inhibitors (BIO-TIMER trial)

Correction: Value of combining biological age with assessment of individual frailty to optimize management of cancer treated with targeted therapies: model of chronic myeloid leukemia treated with tyrosine kinase inhibitors (BIO-TIMER trial)

Bibliographic Details
Main Authors: Mélanie Casile, Gilles Albrand, Clément Lahaye, Benjamin Lebecque, Joévin Besombes, Céline Bourgne, Bruno Pereira, Sandrine Saugues, Caroline Jamot, Eric Hermet, Marc G. Berger
Format: Article
Language:English
Published: BMC 2024-07-01
Series:BMC Cancer
Online Access:https://doi.org/10.1186/s12885-024-12592-0

Internet

https://doi.org/10.1186/s12885-024-12592-0

Similar Items